Skip to main content

Find Clinical Trials

Home
Conditions
Influenza

Clinical trial condition

Influenza

Explore clinical trials studying Influenza. Study availability and eligibility vary by location and protocol.

1,207 public trials 46 recruiting studies

Refine in advanced search Browse all conditions

Influenza trial results

Completed

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

NCT01227421

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Health Sciences Research Center Elmira, New York, United States

View Trial Details

Completed

The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) （Children Forms of Drug）

NCT01551823

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Dingxing Center for Disease Prevention and Control Shijiazhuang, Hebei, China

View Trial Details

Completed

The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)

NCT01551810

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Dingxing Center for Disease Prevention and Control Shijiazhuang, Hebei, China

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

NCT05544916

Conditions: Infections, Influenza, Influenza, Human, +6 more
Locations: State autonomous health care institution "Engels City Clinical Hospital No. 1" Engel's, Russia

Medical Diagnostic Center "Medexpert", LLC Engel's, Russia

Unimed-C Jsc Moscow, Russia

Professors' Clinic LLC. Perm, Russia

View all 13 locations

View Trial Details

Completed

Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers

NCT05558462

Conditions: Infections, Influenza, Influenza, Human, +6 more
Locations: I.M. Sechenov First Moscow State Medical University Moscow, Russia

View Trial Details

Completed

Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.'

NCT02677493

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Not specified

View Trial Details

Completed

Assessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake

NCT04678271

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +10 more
Locations: Yale New Haven Hospital New Haven, Connecticut, United States

View Trial Details

Completed

Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine

NCT03287830

Conditions: Infections, Influenza, Influenza, Human, +6 more
Locations: American Academy of Pediatrics Itasca, Illinois, United States

Columbia University Medical Center New York, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers.

NCT05060887

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Centre for Vaccinology (CEVAC) Ghent, Belgium

View Trial Details

Completed

Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults

NCT03301051

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Site 222 Mobile, Alabama, United States

Site 210 Anaheim, California, United States

Site 223 Milford, Connecticut, United States

Site 217 Coral Gables, Florida, United States

View all 73 locations

View Trial Details